Nature Ecology & Evolution · 2021 · 74 citations · 36 references
MedicineCancer BiologyOncologyNeoplasiaTumor HeterogeneityTumor ProgressionClonal DynamicsClonal EvolutionKidney CancerMalignant TumorsRenal Cell CarcinomaTumor Growth KineticsClonal DiversificationClonal Evolution AnalysisClonal ExpansionClonal GrowthRenal Cell Carcinoma ImagingSpatial-temporal Tumor EvolutionSubclonal DynamicsTumor Clonal Evolution
Genetic intra-tumour heterogeneity fuels clonal evolution, but our understanding of clinically relevant clonal dynamics remain limited. We investigated spatial and temporal features of clonal diversification in clear cell renal cell carcinoma through a combination of modelling and real tumour analysis. We observe that the mode of tumour growth, surface or volume, impacts the extent of subclonal diversification, enabling interpretation of clonal diversity in patient tumours. Specific patterns of proliferation and necrosis explain clonal expansion and emergence of parallel evolution and microdiversity in tumours. In silico time-course studies reveal the appearance of budding structures before detectable subclonal diversification. Intriguingly, we observe radiological evidence of budding structures in early-stage clear cell renal cell carcinoma, indicating that future clonal evolution may be predictable from imaging. Our findings offer a window into the temporal and spatial features of clinically relevant clonal evolution.
36
Tracking the Evolution of Non–Small-Cell Lung Cancer
Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicholas McGranahan et al. · New England Journal of Medicine · 2017 · 2.4K citations · Full text
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh, Nicolai J. Birkbak, Gareth A. Wilson et al. · Nature · 2017 · 1.9K citations · Full text
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela, Patrick Tarpey, Keiran Raine et al. · Nature · 2011 · 1.3K citations
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Ayse Bassez, Hanne Vos, Laurien Van Dyck et al. · Nature Medicine · 2021 · 915 citations · Full text
Medicine, Cancer Biology, Oncology +17